Updates
Nexus BioPharma is working with a major Clinical Research Organization (CRO) on the drug development screening. We have also received validation from the scientific community, most recently with a poster at the Royal Society of Chemistry's Kinase 2016 Next Generation Inhibitors held in May in Nottingham, England.
Read More About The Pipeline of Development...